Bing

SEARCH HISTORY

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Keryx Biopharmaceuticals Inc. (KERX) entered into oversold territory, hitting an RSI reading of 26.7, after changing …
The Street · 7/24/2015
Stock analysts at Roth Capital cut their price target on shares of Keryx Biopharmaceuticals (NASDAQ:KERX) from $23.00 to $11.00 in a report issued on Thursday, Analyst Ratings.Net reports. The firm currently has a “buy” rating on the …
Ticker Report · 7/23/2015
The stock was purchased at an average price of $9.73 per share, with a total value of $97,300.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Shares of Keryx Biopharmaceuticals (NASDAQ:KERX ...
sleekmoney.com · 7/28/2015
More from Bing News
Keryx Biopharmaceuticals (NASDAQ:KERX) opened at 7.84 on Thursday. Keryx Biopharmaceuticals has a 52 week low of $7.67 and a 52 week high of $18.48. The stock has a 50-day moving average of $9.80 and a 200-day moving average of $11.48. The …
Mideast Times · 7/26/2015
The stock should find initial resistance at its 50-day moving average (MA) of $9.82 and further resistance at its 200-day MA of $12.57. Over the past year, Keryx Biopharmaceuticals has traded in a range of $1.28 to $18.48 and is now at $7.58, 492% above ...
Financial News Network Online · ByMallory Stone · 7/30/2015
Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) traded down 5.346% on Thursday, hitting $8.765. 913,983 shares of the company’s stock traded hands. Keryx Biopharmaceuticals has a 52-week low of $8.69 and a 52-week high of $18.48. The …
wkrb13.com · 7/24/2015
What: Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), a drug developer with a focus on renal disease ... So if the news was good, why did the stock fall? Today's movement is probably because of Roth Capital, which recently affirmed its buy rating ...
The Motley Fool · 7/24/2015
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) caters to the Healthcare space. Its weekly performance …
Property Mentor Group · 7/28/2015
Stock market Insiders sold stocks of the following NASDAQ companies ... Keryx Biopharmaceuticals (NASDAQ:KERX) – Adams Brian sold 1,086 stocks at $9.99. Advanced Energy Industries (NASDAQ:AEIS) – Ball …
Fx Pips · 7/21/2015
Keryx Biopharmaceuticals (KERX): KERX stock is up 3.8% today ... Article printed from InvestorPlace Media, http://investorplace.com/2015/06/biggest-movers-in-healthcare-stocks-now-bcrx-cldx-cemp-kerx-bcrx-cldx-cemp/.
Investor Place · 6/30/2015